Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Clinical Nutrition Market Projected to Reach $102.42 Billion in 2030 - Rising Demand for Infant and Specialized Nutrition Products

globenewswire.com
ABT Abbott Laboratories is listed as a major player in the clinical nutrition market, which is projected for significant growth. The article does not provide specific positive or negative sentiment towards Abbott itself, but its inclusion as a key player suggests relevance to the growing market. NDSN Nestle S.A. is identified as a major player in the expanding clinical nutrition market. The article highlights the overall market growth and trends, but does not offer specific sentiment for Nestle's performance or prospects within this context. BAX Baxter Healthcare Ltd. is mentioned as a major player in the clinical nutrition market. The article focuses on the market's overall growth and trends, without providing specific sentiment or performance indicators for Baxter.

Clinical Nutrition Market Projected to Reach $102.42 Billion in 2030 - Rising Demand for Infant and Specialized Nutrition Products Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Clinical Nutrition Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The clinical nutrition market has significantly expanded over recent years, progressing from $64.37 billion in 2025 to an anticipated $70.42 billion by 2026, at a CAGR of 9.4%. This growth is attributed to factors such as the limited availability of specialized nutrition products and the expansion of hospital and clinical infrastructure. As the prevalence of chronic diseases rises and awareness about malnutrition grows, enteral and parenteral solutions are becoming standard.

The market is poised to reach approximately $102.42 billion by 2030, maintaining a steady CAGR of 9.8%. This anticipated growth stems from the development of disease-specific and personalized nutrition formulas, the expansion of home care and tele-nutrition services, and increased adoption of digital monitoring tools.

Key trends shaping the future include the rising demand for infant nutrition products, increased adoption of specialized formulas in hospitals, and growth in nutritional therapies tailored for cancer and metabolic disorders. The integration of home care and remote nutritional monitoring services, alongside the expansion of clinical nutrition programs for geriatrics and adults, further underpins this trajectory.

The rising geriatric population, a key market driver, often requires specialized nutritional care due to vulnerabilities in age-related health issues. Statistics from the Office for National Statistics indicate a growing population of those aged 90 and above in the UK, contributing to heightened demand for clinical nutrition. The geriatric demographic benefits from tailored dietary solutions to maintain health and manage chronic conditions.

Innovation in technological solutions, such as semi-solid enteral nutrition formulations, addresses the need for patient-friendly options. These products lower reflux risks, enhance gastric tolerance, and improve nutrient absorption. For instance, Otsuka Pharmaceutical Factory Inc. introduced the ENOSOLID Semi Solid for Enteral Use, a gel-like formulation aimed at meeting dietary needs while reducing energy expenditure.

Strategic industry moves, such as Danone S.A.'s acquisition of a majority stake in Kate Farms Inc., underscore the market shift toward integrating plant-based and organic nutrition products into clinical practices. This partnership strengthens Danone's presence in the U.S. medical nutrition sector, enhancing their portfolio with Kate Farms' innovative formulations.

The major players in this dynamic market include Abbott Laboratories, Nestle S.A., Baxter Healthcare Ltd., Danone S.A., and Fresenius Kabi AG, among others. North America led the market in 2025, with widespread coverage in Asia-Pacific, Europe, and beyond.

Tariffs pose challenges, increasing costs for imported raw materials and specialized formulations. Yet, they also spur local manufacturing and domestic innovation. As a hub for clinical nutrition insights, the market research report offers a comprehensive overview of market sizes, regional shares, and trends. As the market evolves, the demand for tailored nutrition in combating metabolic disorders and supporting vulnerable populations remains a critical focus.

Report Scope

The report is pivotal for identifying the largest and fastest-growing markets within clinical nutrition, understanding market interaction with the broader economy, demography, and parallel markets. It evaluates technological disruption, regulatory shifts, and changing consumer preferences.

Key areas the report covers include market characteristics, size and growth, segmentation, regional and country breakdowns, TAM, market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends, and strategic advice.

Markets Covered:

Companies Mentioned: Abbott Laboratories, Nestle S.A., Baxter Healthcare Ltd., and others.

Countries and Regions Covered: Australia, Brazil, China, France, Germany, and key regions like Asia-Pacific, North America, and others.

Time Series: Includes five years of historical and ten years of forecast data.

Data Sources: The report employs a qualified data sourcing strategy, with end notes provided for all data points.

Delivery Format: Available in Word, PDF, or Interactive Report with Excel Dashboard.

Added Benefits:

Key Attributes

The companies featured in this Clinical Nutrition market report include:

For more information about this report visit https://www.researchandmarkets.com/r/xm9eh0

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment